PALB2 mutations and prostate cancer risk and survival.
Wokołorczyk D, Kluźniak W, Stempa K, Rusak B, Huzarski T, Gronwald J, Gliniewicz K, Kashyap A, Morawska S, Dębniak T, Jakubowska A, Szwiec M, Domagała P, Lubiński J, Narod SA, Akbari MR, Cybulski C; Polish Hereditary Prostate Cancer Consortium.
Wokołorczyk D, et al. Among authors: akbari mr.
Br J Cancer. 2021 Aug;125(4):569-575. doi: 10.1038/s41416-021-01410-0. Epub 2021 May 18.
Br J Cancer. 2021.
PMID: 34006922
Free PMC article.